Skip to main content
logo
REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
9.22
-0.17 (-1.81%)
At close: May 5, 2026, 4:00 PM EDT
9.25
+0.03 (0.33%)
After-hours: May 5, 2026, 7:07 PM EDT

REGENXBIO Employees

REGENXBIO had 371 employees as of December 31, 2025. The number of employees increased by 18 or 5.10% compared to the previous year.

Employees
371
Change (1Y)
18
Growth (1Y)
5.10%
Revenue / Employee
$459,410
Profits / Employee
-$522,582
Market Cap
475.91M

Employees Chart

Employees History

DateEmployeesChange (1Y)Growth (1Y)
Dec 31, 2025371185.10%
Dec 31, 202435392.62%
Dec 31, 2023344-57-14.21%
Dec 31, 2022401297.80%
Dec 31, 20213726621.57%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Related Stocks

Company NameEmployees
Lyell Immunopharma300
4D Molecular Therapeutics196
ADC Therapeutics193
Prelude Therapeutics79
PureTech Health56
Fulcrum Therapeutics55
Atea Pharmaceuticals55
Eupraxia Pharmaceuticals49
Employee Rankings

RGNX News

More News